Accelerate Diagnostics (MEX:AXDX) Shiller PE Ratio: (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:AXDX Accelerate Diagnostics Inc MEX:AXDX
12 GF Score
Price MXN1.75
View Full Analysis

What is Accelerate Diagnostics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Accelerate Diagnostics  (MEX:AXDX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Accelerate Diagnostics Shiller PE Ratio Related Terms


Accelerate Diagnostics Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Accelerate Diagnostics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accelerate Diagnostics Shiller PE Ratio Chart

Accelerate Diagnostics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Accelerate Diagnostics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MEX:AXDX vs MSIU, BIOLQ, AFIB: Shiller PE Ratio Comparison

For the Medical Devices subindustry, Accelerate Diagnostics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accelerate Diagnostics Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's Shiller PE Ratio falls into.


MEX:AXDX
12GF Score
Accelerate Diagnostics Inc MEX:AXDX
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accelerate Diagnostics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Accelerate Diagnostics's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Accelerate Diagnostics's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-7.717/315.6050*315.6050
=-7.717

Current CPI (Dec. 2024) = 315.6050.

Accelerate Diagnostics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -30.490 236.119 -40.754
201506 -42.364 238.638 -56.027
201509 -42.245 237.945 -56.033
201512 -49.866 236.525 -66.538
201603 -49.921 238.132 -66.162
201606 -64.727 241.018 -84.758
201609 -65.741 241.428 -85.939
201612 -63.913 241.432 -83.548
201703 -50.838 243.801 -65.811
201706 -56.036 244.955 -72.198
201709 -56.259 246.819 -71.938
201712 -56.955 246.524 -72.915
201803 -67.220 249.554 -85.012
201806 -84.493 251.989 -105.824
201809 -76.690 252.439 -95.880
201812 -80.503 251.233 -101.130
201903 -77.592 254.202 -96.335
201906 -72.994 256.143 -89.939
201909 -73.045 256.759 -89.786
201912 -73.554 256.974 -90.336
202003 -91.447 258.115 -111.815
202006 -80.787 257.797 -98.903
202009 -72.900 260.280 -88.396
202012 -65.644 260.474 -79.538
202103 -83.808 264.877 -99.859
202106 -71.662 271.696 -83.243
202109 -30.843 274.310 -35.486
202112 -71.594 278.802 -81.045
202203 -39.822 287.504 -43.714
202206 -48.887 296.311 -52.070
202209 -36.810 296.808 -39.141
202212 -27.294 296.797 -29.024
202303 -30.823 301.836 -32.229
202306 -50.917 305.109 -52.669
202309 1.045 307.789 1.072
202312 -13.749 306.746 -14.146
202403 -12.281 312.332 -12.410
202406 -9.160 314.175 -9.202
202409 -11.617 315.301 -11.628
202412 -7.717 315.605 -7.717

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Accelerate Diagnostics Business Description

Address 3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714
Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.
12GF Score

Get the complete analysis for MEX:AXDX

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1.75
Price